These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 8619365

  • 1. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
    Narusawa K, Nakamura T, Suzuki K, Matsuoka Y, Lee LJ, Tanaka H, Seino Y.
    J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
    [Abstract] [Full Text] [Related]

  • 2. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F, Lang K, Dony C, Kling L.
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [Abstract] [Full Text] [Related]

  • 3. Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats.
    Bagi CM, Brommage R, Deleon L, Adams S, Rosen D, Sommer A.
    J Bone Miner Res; 1994 Aug; 9(8):1301-12. PubMed ID: 7526611
    [Abstract] [Full Text] [Related]

  • 4. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, Mosekilde L, Einhorn TA, Bouillon R.
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [Abstract] [Full Text] [Related]

  • 5. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
    Murakami H, Nakamura T, Tsurukami H, Abe M, Barbier A, Suzuki K.
    J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
    Bagi CM, DeLeon E, Brommage R, Adams S, Rosen D, Sommer A.
    Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
    [Abstract] [Full Text] [Related]

  • 8. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
    Clemmons DR, Moses AC, Sommer A, Jacobson W, Rogol AD, Sleevi MR, Allan G.
    Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
    [Abstract] [Full Text] [Related]

  • 9. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats.
    Bourrin S, Ammann P, Bonjour JP, Rizzoli R.
    Endocrinology; 2000 Sep; 141(9):3149-55. PubMed ID: 10965885
    [Abstract] [Full Text] [Related]

  • 10. Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck.
    Bagi CM, DeLeon E, Brommage R, Rosen D, Sommer A.
    Calcif Tissue Int; 1995 Jul; 57(1):40-6. PubMed ID: 7545533
    [Abstract] [Full Text] [Related]

  • 11. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T, Shojaee-Moradie F, Williams RM, Amin R, Yuen KC, Watts A, Acerini CL, Umpleby AM, Dunger DB.
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats.
    Lepola VT, Kippo K, Hannuniemi R, Laurén L, Virtamo T, Osterman T, Jalovaara P, Sellman R, Väänänen HK.
    J Bone Miner Res; 1996 Oct; 11(10):1508-17. PubMed ID: 8889851
    [Abstract] [Full Text] [Related]

  • 13. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
    Wang W, Iresjö BM, Karlsson L, Svanberg E.
    Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
    [Abstract] [Full Text] [Related]

  • 14. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
    Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, Adams S, Broos P, Lenaerts J, Raus J, Vanderschueren D, Geusens P.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
    [Abstract] [Full Text] [Related]

  • 15. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
    Cui L, Wu T, Liu YY, Deng YF, Ai CM, Chen HQ.
    Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats.
    Iwamoto J, Yeh JK, Takeda T.
    J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.